Trial Profile
Serum 14-3-3η (IdentRA) levels as a predictive marker of the therapeutic efficacy of Tocilizumab in the treatment of rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Feb 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 10 Feb 2016 New trial record